|68.44||-0.315 / -0.46%|
Data as of 3:59pm ET
|68.76||+0.315 / +0.46%|
The 9 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 92.00, with a high estimate of 100.00 and a low estimate of 55.00. The median estimate represents a +34.41% increase from the last price of 68.44.
The current consensus among 9 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.